299. Cystic fibrosis Clinical trials / Disease details


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01400750
(ClinicalTrials.gov)
August 200118/7/2011Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic FibrosisProspective Randomized Trial Comparing Oral Ciproxin Plus Inhaled Colistin With Tobramycin for Inhalation for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis.Cystic FibrosisDrug: oral ciprofloxacin plus inhaled colistin;Drug: TOBIUniversitaire Ziekenhuizen LeuvenNULLCompletedN/A18 YearsBoth61Phase 4Belgium
2NCT00006280
(ClinicalTrials.gov)
February 200011/9/2000A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic FibrosisA Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic FibrosisCystic FibrosisDrug: Tobramycin for InhalationNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)National Center for Research Resources (NCRR)Completed6 Months5 YearsBoth98Phase 2United States